Stay updated on Pembrolizumab for Pediatric Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Pediatric Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Pediatric Hodgkin Lymphoma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Revision: v3.6.3 was added and Revision: v3.6.2 was removed. This reflects a minor update to the study record's version metadata.
    Difference
    0.0%
    Check dated 2026-07-06T16:30:10.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.0 to v3.6.2, indicating a minor update to the document's metadata.
    Difference
    0.0%
    Check dated 2026-06-29T09:55:50.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The study page now indicates that enrollment has ended by adding 'No longer looking for participants'. The new sections for How to Read a Study Record, Common Questions, and How to Join a Study were added, while the Intervention/Treatment heading formatting was adjusted and the revision version updated from v3.5.5 to v3.6.0.
    Difference
    0.2%
    Check dated 2026-06-15T08:21:34.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.5.4 to v3.5.5, indicating a minor update to the page metadata or content. It does not alter the study details or eligibility information.
    Difference
    0.0%
    Check dated 2026-06-08T03:56:07.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Revision tag updated from v3.5.3 to v3.5.4, reflecting a minor update to the page's version metadata.
    Difference
    0.0%
    Check dated 2026-05-17T09:08:50.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    The page’s footer “Revision” label has been updated from v3.5.2 to v3.5.3, reflecting a minor platform/version change without altering the displayed trial details.
    Difference
    0.0%
    Check dated 2026-04-25T18:25:24.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Pediatric Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Pediatric Hodgkin Lymphoma Clinical Trial page.